NEGLIGIBLE TUMOR FEARS WITH iPS. “Considering the number of rodents used, the monitoring period, the sensitivity of detecting tumors via subcutaneous and subretinal administration routes and the incidence of tumor formation from the iPSC-derived RPE, we conclude that the tumorigenic potential of the iPSC-derived RPE was negligible.”
http://lnkd.in/dpPjkpG
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022